Clinical Evaluation of NK211 for Ovarian Cancer <Clinical pharmacological study>
Phase 1
- Conditions
- Recurrent ovarian cancer
- Registration Number
- JPRN-jRCT2080220962
- Lead Sponsor
- ippon Kayaku Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
1)Histologic or cytologic diagnosis of ovarian cancer
2)Relapse-patients treated with standard chemotherapy
3)Patient whose prior therapy other than medication doesn't influence evaluation.
4)ECOG PS 0-2
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method